Q2 2024 |
40 |
$1.26B |
+$51.2M |
-$199M |
-$148M |
PLD, EQIX, WELL, SPG, PSA
|
13F-HR |
8/14/2024, 11:48 AM |
Q1 2024 |
41 |
$1.48B |
+$206M |
-$116M |
+$90.6M |
PLD, EQIX, WELL, SPG, PSA
|
13F-HR |
5/15/2024, 04:09 PM |
Q4 2023 |
42 |
$1.44B |
+$240M |
-$206M |
+$34.4M |
PLD, EQIX, WELL, PSA, EQR
|
13F-HR |
2/14/2024, 06:08 PM |
Q3 2023 |
41 |
$1.24B |
+$373M |
-$199M |
+$174M |
PLD, EQIX, WELL, EQR, SPG
|
13F-HR |
11/14/2023, 05:40 PM |
Q2 2023 |
42 |
$1.14B |
+$60.1M |
-$111M |
-$51.2M |
EQIX, WELL, EQR, PSA, KIM
|
13F-HR |
8/14/2023, 05:27 PM |
Q1 2023 |
41 |
$1.14B |
+$93.8M |
-$171M |
-$77.3M |
EQIX, PSA, WELL, EQR, EXR
|
13F-HR |
5/15/2023, 06:17 PM |
Q4 2022 |
40 |
$1.19B |
+$213M |
-$356M |
-$143M |
EQIX, PSA, WELL, EQR, EXR
|
13F-HR |
2/14/2023, 06:01 PM |
Q3 2022 |
41 |
$1.33B |
+$73.9M |
-$238M |
-$164M |
PLD, EQIX, EQR, EXR, ESS
|
13F-HR |
11/14/2022, 06:48 PM |
Q2 2022 |
40 |
$1.66B |
+$96.6M |
-$74.4M |
+$22.2M |
PLD, EQIX, EQR, PSA, WELL
|
Restatement |
8/16/2022, 06:47 PM |
Q1 2022 |
45 |
$2.02B |
+$119M |
-$248M |
-$129M |
PLD, EQIX, EQR, EXR, ESS
|
13F-HR |
5/16/2022, 05:04 PM |
Q4 2021 |
48 |
$2.25B |
+$143M |
-$180M |
-$37.1M |
PLD, EQIX, EXR, EQR, WELL
|
13F-HR |
2/14/2022, 04:49 PM |
Q3 2021 |
44 |
$1.97B |
+$119M |
-$51.2M |
+$68.2M |
PLD, EQIX, WELL, EQR, EXR
|
13F-HR |
11/15/2021, 05:13 PM |
Q2 2021 |
43 |
$1.87B |
+$178M |
-$110M |
+$67.4M |
PLD, EQIX, WELL, EXR, EQR
|
13F-HR |
8/16/2021, 05:32 PM |
Q1 2021 |
35 |
$1.59B |
+$161M |
-$147M |
+$14.7M |
PLD, EQIX, WELL, EQR, EXR
|
13F-HR |
5/17/2021, 04:45 PM |
Q4 2020 |
39 |
$1.46B |
+$61.3M |
-$468M |
-$406M |
PLD, EQIX, ARE, EXR, WELL
|
13F-HR |
2/16/2021, 03:42 PM |
Q3 2020 |
38 |
$1.7B |
+$101M |
-$156M |
-$54.2M |
PLD, EQIX, ARE, EXR, EQR
|
13F-HR |
11/16/2020, 04:38 PM |
Q2 2020 |
39 |
$1.69B |
+$174M |
-$161M |
+$12.7M |
EQIX, PLD, ARE, EQR, EXR
|
13F-HR |
8/14/2020, 04:29 PM |
Q1 2020 |
37 |
$1.57B |
+$196M |
-$182M |
+$14.1M |
EQIX, PLD, EQR, ARE, EXR
|
13F-HR |
5/15/2020, 02:19 PM |
Q4 2019 |
38 |
$2.02B |
+$296M |
-$294M |
+$2.1M |
PLD, SPG, EQIX, EQR, ARE
|
13F-HR |
2/14/2020, 02:20 PM |
Q3 2019 |
37 |
$2.05B |
+$146M |
-$178M |
-$32.5M |
PLD, EQIX, SPG, EQR, ARE
|
13F-HR |
11/13/2019, 03:52 PM |
Q2 2019 |
36 |
$1.94B |
+$115M |
-$240M |
-$125M |
PLD, SPG, EQIX, EQR, ARE
|
13F-HR |
8/14/2019, 10:23 AM |
Q1 2019 |
38 |
$2.04B |
+$207M |
-$221M |
-$13.6M |
SPG, PLD, EQIX, EQR, ESS
|
13F-HR |
5/14/2019, 02:08 PM |
Q4 2018 |
45 |
$1.77B |
+$347M |
-$140M |
+$207M |
SPG, PLD, EQR, EQIX, ARE
|
13F-HR |
2/14/2019, 04:20 PM |
Q3 2018 |
43 |
$1.75B |
+$237M |
-$224M |
+$13M |
SPG, PLD, EQIX, EQR, ARE
|
13F-HR |
11/14/2018, 04:33 PM |
Q2 2018 |
43 |
$1.74B |
+$162M |
-$221M |
-$58.5M |
SPG, EQIX, PLD, ARE, ESS
|
13F-HR |
8/14/2018, 04:38 PM |
Q1 2018 |
39 |
$1.69B |
+$123M |
-$150M |
-$27M |
SPG, EQIX, EQR, PLD, WELL
|
13F-HR |
5/15/2018, 04:42 PM |
Q4 2017 |
43 |
$1.84B |
+$179M |
-$189M |
-$10.3M |
SPG, EQR, WELL, PLD, REG
|
13F-HR |
2/14/2018, 04:02 PM |
Q3 2017 |
40 |
$1.81B |
+$207M |
-$156M |
+$51.2M |
SPG, WELL, EQR, PLD, PSA
|
13F-HR |
11/13/2017, 04:48 PM |
Q2 2017 |
41 |
$1.77B |
+$65.1M |
-$259M |
-$194M |
SPG, PLD, EQR, WELL, REG
|
13F-HR |
8/14/2017, 05:28 PM |
Q1 2017 |
42 |
$1.92B |
+$231M |
-$397M |
-$167M |
SPG, PSA, EQR, PLD, WELL
|
13F-HR |
5/10/2017, 04:55 PM |
Q4 2016 |
43 |
$2.02B |
+$313M |
-$346M |
-$32.1M |
SPG, PSA, EQR, WELL, PLD
|
13F-HR |
2/14/2017, 05:05 PM |
Q3 2016 |
45 |
$2.13B |
+$325M |
-$316M |
+$9.54M |
SPG, PSA, ESS, WELL, PLD
|
13F-HR |
11/15/2016, 05:18 PM |
Q2 2016 |
44 |
$2.17B |
+$217M |
-$203M |
+$14.9M |
SPG, PSA, ESS, WELL, BXP
|
13F-HR |
8/15/2016, 04:46 PM |
Q1 2016 |
42 |
$2.1B |
+$173M |
-$262M |
-$89.8M |
SPG, EQR, WELL, ESS, PSA
|
13F-HR |
5/16/2016, 05:12 PM |
Q4 2015 |
41 |
$2.13B |
+$113M |
-$190M |
-$77.1M |
SPG, EQR, PSA, WELL, ESS
|
13F-HR |
2/12/2016, 04:19 PM |
Q3 2015 |
41 |
$2.09B |
+$356M |
-$307M |
+$49.3M |
SPG, EQR, WELL, PSA, PLD
|
13F-HR |
11/13/2015, 04:08 PM |
Q2 2015 |
42 |
$2B |
+$235M |
-$208M |
+$27.5M |
SPG, EQR, HCN, PLD, PSA
|
13F-HR |
8/17/2015, 04:07 PM |
Q1 2015 |
42 |
$2.18B |
+$144M |
-$258M |
-$113M |
SPG, EQR, HCN, PSA, PLD
|
13F-HR |
5/15/2015, 04:11 PM |
Q4 2014 |
38 |
$2.17B |
+$354M |
-$392M |
-$38.4M |
SPG, EQR, HCN, BXP, PSA
|
13F-HR |
2/13/2015, 05:13 PM |
Q3 2014 |
40 |
$1.97B |
+$333M |
-$195M |
+$138M |
SPG, EQR, BXP, HCN, PSA
|
13F-HR |
11/12/2014, 07:08 PM |
Q2 2014 |
45 |
$1.88B |
+$82.8M |
-$132M |
-$49.5M |
SPG, EQR, BXP, HCP, AVB
|
13F-HR |
8/14/2014, 05:13 PM |
Q1 2014 |
40 |
$1.82B |
+$107M |
-$143M |
-$35.4M |
SPG, EQR, AVB, HCP, VTR
|
13F-HR |
5/15/2014, 04:58 PM |
Q4 2013 |
42 |
$1.7B |
$0 |
$0 |
|
SPG, EQR, HCP, AVB, VTR
|
13F-HR |
2/14/2014, 04:22 PM |